![Yvonne Greenstreet](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yvonne Greenstreet
Vorstandsvorsitzender bei
ALNYLAM PHARMACEUTICALS, INC.
Vermögen: 29 Mio $ am 31.05.2026
Profil
Yvonne L. Greenstreet gründete Highgate LLC. Derzeit ist Dr. Greenstreet President & Chief Operating Officer von Alnylam Pharmaceuticals, Inc. Dr. Greenstreet ist auch im Vorstand von Pacira Biosciences, Inc. und Mitglied der Association of the British Pharmaceutical Industry. Dr. Greenstreet war zuvor Geschäftsführerin bei Highgate LLC, Senior Vice President & Head-Medicines Development bei Pfizer Inc. und Chief Strategy-R&D, Senior Vice President bei GlaxoSmithKline Plc. Yvonne L. Greenstreet erhielt einen MBA von INSEAD und einen Bachelor-Abschluss von der University of Leeds.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 04.03.2026 | 96’102 ( 0.07% ) | 29 Mio $ | 31.05.2026 |
Aktuelle Nachrichten zu Yvonne Greenstreet
Aktive Positionen von Yvonne Greenstreet
| Unternehmen | Position | Beginn |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Vorstandsvorsitzender | 01.01.2022 |
The Association of the British Pharmaceutical Industry
 The Association of the British Pharmaceutical Industry Miscellaneous Commercial ServicesCommercial Services Operates pharmaceutical companies associations | Corporate Officer/Principal | - |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Yvonne Greenstreet
| Unternehmen | Position | Ende |
|---|---|---|
| PACIRA BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 31.03.2023 |
| ARGENX SE | Direktor/Vorstandsmitglied | 03.03.2022 |
Indivior Ltd.
 Indivior Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical drugs | Direktor/Vorstandsmitglied | 31.03.2019 |
| MOELIS & COMPANY | Direktor/Vorstandsmitglied | 31.12.2018 |
Highgate LLC
 Highgate LLC Real Estate DevelopmentFinance Operates nonresidential buildings | Vorstandsvorsitzender | 01.08.2016 |
Ausbildung von Yvonne Greenstreet
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
81
Beziehungen ersten Grades
16
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 16 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Molecular Insight Pharmaceuticals, Inc.
 Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Develops and commercializes innovative molecular imaging pharmaceuticals | Health Services |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Indivior Ltd.
Indivior Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical drugs | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Pacira Biosciences, Inc.
 Pacira Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures injectable therapeutic products | Health Technology |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
University of Leeds
 University of Leeds Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
INSEAD
 INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The American Funds Group
 The American Funds Group Investment Trusts/Mutual FundsMiscellaneous Acts as Open-End Investment Fund/Unit Trust | Miscellaneous |
The Association of the British Pharmaceutical Industry
The Association of the British Pharmaceutical Industry Miscellaneous Commercial ServicesCommercial Services Operates pharmaceutical companies associations | Commercial Services |
argenx SE
 argenx SE BiotechnologyHealth Technology Develops therapies and medicines for the treatment of autoimmune diseases | Health Technology |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Advanced Accelerator Applications SA
 Advanced Accelerator Applications SA Pharmaceuticals: MajorHealth Technology Develops and produces nuclear medicine and radioligand therapies | Health Technology |
Moelis & Co.
 Moelis & Co. Investment Banks/BrokersFinance Provides financial advisory, capital raising and asset management services | Finance |
Highgate LLC
Highgate LLC Real Estate DevelopmentFinance Operates nonresidential buildings | Finance |
